Farallon Capital Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,150,857
| Closed | -$105M | – | 183 |
|
|
2024
Q3 | $105M | Buy |
3,150,857
+210,357
| +7% | +$7.01M | 0.46% | 46 |
|
|
2024
Q2 | $79.5M | Hold |
2,940,500
| – | – | 0.34% | 46 |
|
|
2024
Q1 | $63.5M | Buy |
2,940,500
+1,380,000
| +88% | +$29.8M | 0.27% | 52 |
|
|
2023
Q4 | $9.41M | Hold |
1,560,500
| – | – | 0.04% | 81 |
|
|
2023
Q3 | $8.68M | Buy |
1,560,500
+560,500
| +56% | +$3.12M | 0.04% | 90 |
|
|
2023
Q2 | $7.34M | Sell |
1,000,000
-560,500
| -36% | -$4.11M | 0.04% | 95 |
|
|
2023
Q1 | $5.29M | Buy |
1,560,500
+750,000
| +93% | +$2.54M | 0.03% | 120 |
|
|
2022
Q4 | $2.64M | Hold |
810,500
| – | – | 0.02% | 163 |
|
|
2022
Q3 | $3.02M | Hold |
810,500
| – | – | 0.02% | 197 |
|
|
2022
Q2 | $2.5M | Hold |
810,500
| – | – | 0.01% | 201 |
|
|
2022
Q1 | $4.33M | Hold |
810,500
| – | – | 0.02% | 192 |
|
|
2021
Q4 | $3.92M | Hold |
810,500
| – | – | 0.02% | 193 |
|
|
2021
Q3 | $7.17M | Hold |
810,500
| – | – | 0.03% | 164 |
|
|
2021
Q2 | $7.39M | Hold |
810,500
| – | – | 0.03% | 156 |
|
|
2021
Q1 | $13.3M | Buy |
+810,500
| New | +$13.3M | 0.07% | 121 |
|